| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.27▲ | 1.29▼ | 1.29▼ | 1.30▼ | 1.35▼ |
| MA10 | 1.27▲ | 1.30▼ | 1.31▼ | 1.31▼ | 1.47▼ |
| MA20 | 1.29▼ | 1.30▼ | 1.30▼ | 1.40▼ | 1.33▼ |
| MA50 | 1.29▼ | 1.30▼ | 1.31▼ | 1.47▼ | 1.27▲ |
| MA100 | 1.30▼ | 1.35▼ | 1.41▼ | 1.29▼ | 1.39▼ |
| MA200 | 1.38▼ | 1.50▼ | 1.50▼ | 1.27▲ | 54,611.82▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.004▼ | -0.002▼ | -0.011▼ | 0.391▲ |
| RSI | 48.002▼ | 45.064▼ | 43.781▼ | 40.383▼ | 30.100▼ |
| STOCH | 41.667 | 15.865▼ | 36.453 | 22.946 | 28.272 |
| WILL %R | -50.000 | -76.471▼ | -76.471▼ | -86.792▼ | -78.869▼ |
| CCI | 15.603 | -103.753▼ | -145.833▼ | -90.248 | -74.486 |
|
Tuesday, June 30, 2026 05:26 AM
Key U.S. patent now protects exclusivity for developing stenoparib with the stenoparib-DRP® until April 2042 TARPON SPRINGS, Fla., June 30, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the ...
|
|
Thursday, June 18, 2026 05:14 AM
The poster outlines the scientific background, study design, and clinical rationale for the Company’s ongoing Phase 2 trial evaluating stenoparib in patients with advanced platinum-resistant or ...
|
|
Wednesday, December 31, 2025 05:00 AM
TARPON SPRINGS, Fla., December 31, 2025 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/07/26 | 1.29 | 1.30 | 1.26 | 1.28 | 60,521 |
| 02/07/26 | 1.30 | 1.40 | 1.28 | 1.31 | 116,466 |
| 01/07/26 | 1.28 | 1.34 | 1.28 | 1.33 | 121,808 |
| 30/06/26 | 1.28 | 1.3347 | 1.26 | 1.29 | 166,698 |
| 29/06/26 | 1.30 | 1.3437 | 1.26 | 1.30 | 70,521 |
| 26/06/26 | 1.28 | 1.3559 | 1.28 | 1.30 | 120,045 |
| 25/06/26 | 1.30 | 1.3499 | 1.245 | 1.27 | 147,194 |
| 24/06/26 | 1.33 | 1.35 | 1.285 | 1.30 | 67,291 |
| 23/06/26 | 1.32 | 1.3601 | 1.30 | 1.32 | 72,547 |
| 22/06/26 | 1.42 | 1.51 | 1.27 | 1.36 | 153,189 |
|
|
||||
|
|
||||
|
|